➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Harvard Business School
Medtronic
Merck
Boehringer Ingelheim
Moodys

Last Updated: May 18, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR CHLOROQUINE HYDROCHLORIDE

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Chloroquine Hydrochloride

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00074841 Trial of Azithromycin Plus Chloroquine Versus Sulfadoxine-Pyrimethamine Plus Chloroquine for the Treatment of Uncomplicated Malaria in India Completed Pfizer Phase 2/Phase 3 2003-09-01 This primary objective of this study is to assess whether the combination of Azithromycin with chloroquine is non-inferior to the combination of sulfadoxine-pyrimethamine plus chloroquine, when used to treat uncomplicated cases of malaria due to Plasmodium falciparum in adults in India.
NCT00082563 Azithromycin in Combination With Chloroquine Versus Chloroquine in the Eradication of Asymptomatic Plasmodium Falciparum Terminated Pfizer Phase 2 2004-08-01 The purpose of this study is to determine if Azithromycin in combination with chloroquine is superior to chloroquine alone in eradicating P. falciparum asexual parasitemia in asymptomatic, semi-immune adults in Western Kenya.
NCT00082576 Azithromycin Plus Chloroquine Versus Mefloquine for the Treatment of Uncomplicated Malaria in Africa Completed Pfizer Phase 2/Phase 3 2004-06-01 The primary objective is to confirm the hypothesis that azithromycin plus chloroquine is non-inferior to mefloquine for the treatment of symptomatic, uncomplicated malaria due to P. falciparum.
NCT00084227 Azithromycin Plus Chloroquine Versus Atovaquone-Proguanil For The Treatment Of Uncomplicated Plasmodium Falciparum Malaria In South America Completed Pfizer Phase 2/Phase 3 2004-07-01 The primary objective is to confirm the hypothesis that azithromycin plus chloroquine is non-inferior to atovaquone-proguanil for the treatment of symptomatic, uncomplicated malaria due to P. falciparum.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Chloroquine Hydrochloride

Condition Name

Condition Name for Chloroquine Hydrochloride
Intervention Trials
Malaria 65
COVID-19 48
Vivax Malaria 19
Malaria, Falciparum 13
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Chloroquine Hydrochloride
Intervention Trials
Malaria 132
Malaria, Vivax 41
Malaria, Falciparum 37
Coronavirus Infections 33
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Chloroquine Hydrochloride

Trials by Country

Trials by Country for Chloroquine Hydrochloride
Location Trials
United States 53
Brazil 32
Netherlands 16
Thailand 16
India 12
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Chloroquine Hydrochloride
Location Trials
New York 11
Maryland 7
Missouri 6
Pennsylvania 3
Minnesota 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Chloroquine Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Chloroquine Hydrochloride
Clinical Trial Phase Trials
Phase 4 59
Phase 3 73
Phase 2/Phase 3 31
[disabled in preview] 53
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Chloroquine Hydrochloride
Clinical Trial Phase Trials
Completed 125
Not yet recruiting 81
Recruiting 56
[disabled in preview] 15
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Chloroquine Hydrochloride

Sponsor Name

Sponsor Name for Chloroquine Hydrochloride
Sponsor Trials
University of Oxford 19
London School of Hygiene and Tropical Medicine 15
National Institute of Allergy and Infectious Diseases (NIAID) 13
[disabled in preview] 13
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Chloroquine Hydrochloride
Sponsor Trials
Other 535
Industry 43
U.S. Fed 24
[disabled in preview] 19
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
McKinsey
AstraZeneca
Colorcon
Express Scripts
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.